Stonehage Fleming (UK)’s Bristol-Myers Squibb BMY Stock Holding History

Stonehage Fleming (UK)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$2.81M	Sell	40,850 -4,400	-10%	-$291K	1.28%	12
2015 Q3	$2.68M	Hold	45,250	–	–	1.28%	10
2015 Q2	$3.01M	Hold	45,250	–	–	1.36%	9
2015 Q1	$2.92M	Sell	45,250 -1,200	-3%	-$75.1K	1.35%	9
2014 Q4	$2.74M	Hold	46,450	–	–	1.35%	13
2014 Q3	$2.38M	Hold	46,450	–	–	1.06%	18
2014 Q2	$2.25M	Hold	46,450	–	–	0.91%	50
2014 Q1	$2.41M	Hold	46,450	–	–	1.02%	38
2013 Q4	$2.47M	Buy	+46,450	New	+$2.37M	1%	37

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Stonehage Fleming (UK)'s BMY Position: Q4 2015 in Review

Stonehage Fleming (UK) reduced its Bristol-Myers Squibb (BMY) stake by 9.7% in Q4 2015, selling an estimated $291K and leaving 40,850 shares worth $2.81M. The position accounts for 1.28% of the portfolio, ranked #12.

Stonehage Fleming (UK) first reported a position in BMY in Q4 2013 and has held it in 9 quarters since. The position peaked at $3.01M in Q2 2015. 1,535 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

Stonehage Fleming (UK) held 40,850 shares of Bristol-Myers Squibb worth $2.81M as of Q4 2015.
Stonehage Fleming (UK) sold 4,400 Bristol-Myers Squibb shares in Q4 2015, an estimated $291K.
Bristol-Myers Squibb made up 1.28% of Stonehage Fleming (UK)'s portfolio in Q4 2015, its #12 holding.
Stonehage Fleming (UK) first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 9 quarters since.
Stonehage Fleming (UK)'s Bristol-Myers Squibb position peaked at $3.01M in Q2 2015.
1,535 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q4 2015, filed 11 Oct 2019.